← Back to Clinical Trials
Recruiting NCT05452681

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

Trial Parameters

Condition Breast Cancer
Sponsor University of Alabama at Birmingham
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex FEMALE
Min Age 18 Years
Max Age 44 Years
Start Date 2022-06-01
Completion 2025-12-30
All Conditions
Breast Cancer Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage IA Breast Cancer AJCC v8 Anatomic Stage IB Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIA Breast Cancer AJCC v8 Anatomic Stage IIB Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Prognostic Stage I Breast Cancer AJCC v8 Prognostic Stage IA Breast Cancer AJCC v8 Prognostic Stage IB Breast Cancer AJCC v8 Prognostic Stage II Breast Cancer AJCC v8 Prognostic Stage IIA Breast Cancer AJCC v8 Prognostic Stage IIB Breast Cancer AJCC v8 Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
Educational InterventionQuality-of-Life AssessmentQuestionnaire Administration

Brief Summary

The purpose of this two-arm pilot RCT is to evaluate processes and preliminary outcomes of a targeted QOL intervention vs. an attention control among young AA survivors post-treatment for early (I-II) \& late (III) stage breast cancer.

Eligibility Criteria

Inclusion Criteria: * Biologically born women * Self-identify as AA * Are aged 18 to 44 years on study entry * Are diagnosed with breast cancer stage I-III * Have completed treatment with chemotherapy and/or radiation for stage I-III breast cancer prior to study entry * Are English- speaking * Have telephone and internet access Exclusion Criteria: * Participation in formal survivorship navigation programs because they are associated with improved health- related outcomes, which could be a confounder

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE BREAST CANCER TRIALS